Trial
NCT00575419
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
—
Condition
Contrast Induced Nephropathy
Intervention
N-acetylcysteine
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-02